Archean Chemical Industries Ltd
Archean Chemical Industries Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Bromine volumes for FY '26:** Targeted increase to 22,000 - 25,000 tons (including captive consumption), surpassing FY '25 volumes of ~18,000 tons. Bromine volumes targeted to increase to 22,000-25,000 tons in FY '26, with growing demand and contracts underpinning confidence.
From Archean Chemical Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- **Bromine volumes for FY '26:** Targeted increase to 22,000 - 25,000 tons (including captive consumption), surpassing FY '25 volumes of ~18,000 tons.
- **Bromine derivatives:** Targeting at least 10,000 tons sales in FY '26, with a strong start of 500 tons sold in Q4 FY '25, indicating potential upside.
- **Industrial Salt volumes for FY '26:** Expected to exceed 4 million tons, with capacity expanded to over 5 million tons annually after commissioning of additional washery.
- **Revenue from Oren Hydrocarbons:** Estimated INR 150 crores for FY '26, with peak potential previously near INR 500 crores pre-troubles.
- **Pricing outlook:** Salt prices largely stable with occasional minor drops; bromine pricing expected to maintain or modestly increase with long-term contracts priced about 20% below spot rates.
- **Strategic growth:** Focus on bromine and derivatives expansion, plus new initiatives in semiconductor and energy storage sectors supporting long-term growth.
Profitability & Margins
See what Archean Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Bromine derivatives business: Total planned capex of around INR250 crores; INR160-170 crores already spent. Additional capex for flame retardant project within the original budget; commissioning expected by FY '26 end.
- Oren Hydrocarbons: Acquisition cost approximately INR77 crores plus ~INR10 crores refurbishment. Total budgeted capex INR25-30 crores; no large incremental capex planned beyond this.
- SOP (Sulphate of Potash) plant startup: Estimated capex of INR20-30 crores expected between now and September-October.
- Semiconductor project: Land acquisition completed; major capex planned for next year, with INR50-60 crores capex possibly in FY '26.
- Offgrid Energy Labs (zinc-bromide battery business): Progressing on site and vendor selection; no large capex currently.
- Salt business: No major capex except for routine maintenance and operational scale-up.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Archean Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the current or expected order book or pending orders for Archean Chemical Industries Limited.
- However, management highlighted strong contracts for bromine with visibility on growth for FY '26 (targeting 22,000 to 25,000 tons in sales).
- Long-term bromine contracts continue without price reductions, indicating stability and ongoing demand.
- Industrial salt sales have recovered strongly with volumes reaching 1.3 million tons in Q4 FY '25 and capacity expanded to over 5 million tons annually, supported by long-term customer contracts.
- The derivatives business, though in early stages, shows promise with 500 MT sold in Q4 FY '25 and a target of 10,000 MT for FY '26.
- Oren Hydrocarbons are operational in parts with revenues expected around INR 150 crores this year, indicating growing business from the acquired asset.
Archean Chemical Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹301 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Archean Chemical's management said in earlier quarters
- Q1 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- Clean Science (Q4 FY25)
2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.
- Yasho Industries (Q4 FY25)
Exports continue to be a key revenue driver, contributing around 67% of total revenue. Key concall takeaways from Yasho Industries's Q4 FY25 earnings call…
- Vinati Organics (Q4 FY25)
Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…
- PCBL Chemical (Q4 FY25)
Export sales volume for Carbon Black grew strongly by 16.8% in Q4 FY'25, reflecting strong international demand. Key concall takeaways from PCBL Chemical's Q4…
Frequently Asked Questions
What were Archean Chemical Industries Ltd Q4 FY25 results?
Bromine volumes for FY '26:** Targeted increase to 22,000 - 25,000 tons (including captive consumption), surpassing FY '25 volumes of ~18,000 tons. Bromine volumes targeted to increase to 22,000-25,000 tons in FY '26, with growing demand and contracts underpinning confidence.
What is Archean Chemical Industries Ltd share price analysis?
Archean Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 66.8 with a market cap of ₹6,467 Cr. Investors should review the full earnings analysis for detailed insights.
Is Archean Chemical Industries Ltd planning capital expenditure?
Bromine derivatives business: Total planned capex of around INR250 crores; INR160-170 crores already spent.
Keep Archean Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.